Ryman Healthcare (RYM) has announced a fully underwritten capital increase of ~NZ$900m, largely to pay back the outstanding USPP debt and associated break fees; Together with the announcement, RYM provided a comprehensive strategy shift, building on what it announced in October 2022
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.